Trials / Completed
CompletedNCT06789874
To Compare the Efficacy of Intralesional Saline Versus 35% Trichloracetic Acid (TCA) Peel in the Treatment of Atrophic Acne Scars
Comparing the Efficacy of Intralesional Saline Versus 35% Trichloracetic Acid (TCA) Peel in the Treatment of Atrophic Acne Scars
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- Sheikh Zayed Medical College · Other Government
- Sex
- All
- Age
- 16 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to compare the efficacy of intradermal normal saline versus trichloroacetic acid (TCA) in treating atrophic acne scars. Atrophic acne scars are a common and disfiguring complication, with limited research on the use of normal saline.
Detailed description
Acne vulgaris is a common skin problem affecting adolescents and adults. It is the eighth most common skin disease globally, having a prevalence ranging from 35%-85%, with notable variations across different regions and age groups.A randomized controlled trial was conducted at the Dermatology Department, Sheikh Zayed Hospital, Rahim Yar Khan, from 1st April 2023 to 31st October 2023. 126 patients were enrolled. Scar grading was based on Goodman and Baron's Qualitative Scar Classification. The Observer Scar Assessment Scale (OSAS) was used by dermatologists. Patients rated their acne scars using the Visual Disease Severity Scale. Photographs were taken for comparison. Efficacy was defined as ≥50% improvement in the OSAS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Intralesional Saline | Intralesional Saline injected in scars |
| PROCEDURE | 35% trichloracetic acid peel | 35%Trichloracetic acid peel was applied to scars monthly for 3 months |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2023-06-30
- Completion
- 2023-10-31
- First posted
- 2025-01-23
- Last updated
- 2025-01-23
Locations
2 sites across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06789874. Inclusion in this directory is not an endorsement.